Page last updated: 2024-12-06

trimethylsilanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID66110
CHEMBL ID4238997
MeSH IDM0157153

Synonyms (23)

Synonym
silanol, trimethyl-
hydroxytrimethylsilane
trimethylsilanol ,
einecs 213-914-1
ccris 1320
hydroxy(trimethyl)silane
1066-40-6
z4bin3300p ,
silanol, 1,1,1-trimethyl-
unii-z4bin3300p
AKOS006229083
trimethylhydroxysilane
trimethylsilyl alcohol
DTXSID7061433
FT-0697258
mfcd02751657
trimethylsilanol, >=97.5% (gc)
c3h10osi
Q416218
trimethyl-silanol
CHEMBL4238997
? trimethylsilanol
trimethylsilano
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1393287Antibacterial activity against Escherichia coli C3000 ATCC 15597 assessed as lowest concentration required for 7-log reduction in viable bacteria count after 1 hr2018Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9
Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds.
AID1393290Antibacterial activity against Enterococcus faecalis ATCC 19433 assessed as lowest concentration required for 7-log reduction in viable bacteria count after 1 hr2018Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9
Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds.
AID1393289Antibacterial activity against Pseudomonas aeruginosa ATCC 10145 assessed as lowest concentration required for 7-log reduction in viable bacteria count after 1 hr2018Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9
Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds.
AID1393288Antibacterial activity against Staphylococcus aureus assessed as lowest concentration required for 7-log reduction in viable bacteria count after 1 hr2018Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9
Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds.
AID1416903Drug level in deuterated phosphate buffer/D2O at pD 7 treated with 3-Trimethylsilylmethylimidazotetrazine measured every 15 mins for 12 to 18 hrs by 1H NMR method
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (6.67)18.7374
1990's0 (0.00)18.2507
2000's4 (26.67)29.6817
2010's10 (66.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 43.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index43.63 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index5.12 (4.65)
Search Engine Demand Index60.73 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (43.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.25%)6.00%
Case Studies1 (6.25%)4.05%
Observational0 (0.00%)0.25%
Other14 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]